The prostate-specific membrane antigen (PSMA) has received increased consideration
during the past few years as an excellent target for both imaging and therapy of prostate …

Recently, positron emission tomography (PET) imaging using PSMA-ligands has gained
high attention as a promising new radiotracer in patients with prostate cancer (PC). Several …

Purpose: Sensitive detection of cancer foci in men experiencing biochemical recurrence
following initial treatment of prostate cancer is of great clinical significance with a possible …

We previously demonstrated the ability to detect metastatic prostate cancer using N-[N-[(S)-
1, 3-dicarboxypropyl] carbamoyl]-4-18F-fluorobenzyl-l-cysteine (18F-DCFBC), a low …

Purpose: We prospectively evaluated the amino acid analogue positron emission
tomography radiotracer anti-3-[18F] FACBC compared to ProstaScint®(111In-capromab …

Purpose To compare the diagnostic performance of the synthetic amino acid analogue PET
radiotracer anti-3-[18 F] FACBC (fluciclovine) with that of CT in the detection of recurrent …

PET is a functional imaging method that can exploit various aspects of tumor biology to
enable greater detection of prostate cancer than can be provided by morphologic imaging …

Imaging is playing an increasingly important role in the detection of prostate cancer (PCa).
This review summarizes the key imaging modalities–multiparametric ultrasound (US) …

Purpose To characterize uptake of 1-amino-3-fluorine 18-fluorocyclobutane-1-carboxylic
acid (18F FACBC) in patients with localized prostate cancer, benign prostatic hyperplasia …

Anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid (18F-FACBC) is a synthetic amino
acid analog PET radiotracer undergoing clinical trials for the evaluation of prostate and other …